St. Cloud State University and Veeva Systems have announced a partnership to enable medtech clinical research students with hands-on technology training.
SCSU will integrate Veeva Vault eTMF into its graduate curriculum for the Applied Clinical Research Program located in Plymouth, Minn. starting in the Fall 2023 semester.
“Partnering with Veeva will enrich our curriculum and provide students with an applied understanding of industry-leading technology,” said Will Collis-Prather, assistant professor and director, Applied Clinical Research Program at St. Cloud State University. “Students’ familiarity with a modern digital clinical operations application improves their job readiness so they can quickly deliver value to current or future employers.”
Students in SCSU’s Applied Clinical Research Program are either medtech industry professionals looking to grow their careers or experienced individuals seeking to enter the clinical research profession. With access to advanced clinical applications, they will learn how to manage a digital trial master file (TMF), perform audits to ensure inspection readiness, measure process completion cycle times, and use metrics to assess the health of a study.
“We’re excited to advance the medtech community of professionals, academics, and students who are passionate about moving the industry forward,” said Seth Goldenberg, Ph.D., vice president, Veeva MedTech. “Students at St. Cloud State University represent the next generation of all-digital execution, and we welcome the opportunity to support their training and education with Veeva Vault eTMF.”
More than 450 biopharma and medtech companies use Vault eTMF to manage and automate trial processes and improve information exchange across stakeholders. See a demo for more on Vault eTMF for medtech.
About Veeva Systems
Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world’s largest biopharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.
